These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37227152)

  • 21. Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity.
    Liu YH; Li A; Shao J; Xie CZ; Song XQ; Bao WG; Xu JY
    Dalton Trans; 2016 May; 45(19):8036-49. PubMed ID: 27071545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Example of two novel thiocyanato bridged copper (II) complexes derived from substituted thiosemicarbazone ligand: structural elucidation, DNA/albumin binding, biological profile analysis, and molecular docking study.
    Biswas N; Saha S; Khanra S; Sarkar A; Prasad Mandal D; Bhattacharjee S; Chaudhuri A; Chakraborty S; Roy Choudhury C
    J Biomol Struct Dyn; 2019 Jul; 37(11):2801-2822. PubMed ID: 30101692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
    Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
    Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling.
    Chen J; Deng Y; Wang J; Chen S; Peng F; He X; Liu M; Luo H; Zhang J; Chen L
    J Biol Inorg Chem; 2021 Oct; 26(7):793-808. PubMed ID: 34459988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
    Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
    J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity.
    Deka B; Sarkar T; Banerjee S; Kumar A; Mukherjee S; Deka S; Saikia KK; Hussain A
    Dalton Trans; 2017 Jan; 46(2):396-409. PubMed ID: 27929173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity.
    Villarreal W; Colina-Vegas L; Visbal G; Corona O; Corrêa RS; Ellena J; Cominetti MR; Batista AA; Navarro M
    Inorg Chem; 2017 Apr; 56(7):3781-3793. PubMed ID: 28290674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II) complex.
    Chen Z; Wu Y; Zhu Z; Zhang Y
    Biometals; 2019 Apr; 32(2):227-240. PubMed ID: 30659452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and in vitro antitumor activity evaluation of copper(II) complexes with 5-pyridin-2-yl-[1,3]dioxolo[4,5-g]isoquinoline derivatives.
    Zhang YL; Deng CX; Zhou WF; Zhou LY; Cao QQ; Shen WY; Liang H; Chen ZF
    J Inorg Biochem; 2019 Dec; 201():110820. PubMed ID: 31518871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
    Annaraj B; Balakrishnan C; Neelakantan MA
    J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
    Khan S; Malla AM; Zafar A; Naseem I
    PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mononuclear Cu (II) terpyridine complexes: Impact of fused ring thiophene and thiazole head groups towards DNA/BSA interaction, cleavage and antiproliferative activity on HepG2 and triple negative CAL-51 cell line.
    Manikandamathavan VM; Thangaraj M; Weyhermuller T; Parameswari RP; Punitha V; Murthy NN; Nair BU
    Eur J Med Chem; 2017 Jul; 135():434-446. PubMed ID: 28475971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.
    Gou Y; Zhang Y; Qi J; Chen S; Zhou Z; Wu X; Liang H; Yang F
    Oncotarget; 2016 Oct; 7(41):67004-67019. PubMed ID: 27564255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.
    Li XJ; Zheng K; Wang LD; Li YT; Wu ZY; Yan CW
    J Inorg Biochem; 2013 Nov; 128():97-107. PubMed ID: 23948578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homo- and heteroleptic trimethoxy terpyridine-Cu(ii) complexes: synthesis, characterization, DNA/BSA binding, DNA cleavage and cytotoxicity studies.
    Jain S; Bhar K; Kumar S; Bandyopadhyaya S; Tapryal S; Mandal CC; Sharma AK
    Dalton Trans; 2020 Apr; 49(13):4100-4113. PubMed ID: 32141470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.
    Shao J; Ma ZY; Li A; Liu YH; Xie CZ; Qiang ZY; Xu JY
    J Inorg Biochem; 2014 Jul; 136():13-23. PubMed ID: 24690556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
    Liu M; Song XQ; Wu YD; Qian J; Xu JY
    Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cu(ii) and V(iv)O complexes with tri- or tetradentate ligands based on (2-hydroxybenzyl)-l-alanines reveal promising anticancer therapeutic potential.
    Ribeiro N; Bulut I; Cevatemre B; Teixeira C; Yildizhan Y; André V; Adão P; Pessoa JC; Acilan C; Correia I
    Dalton Trans; 2021 Jan; 50(1):157-169. PubMed ID: 33290472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
    Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
    Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.